Clinical Trials Directory

Trials / Terminated

TerminatedNCT05842343

Food Intake and IgA Microbiota in Anorexia Nervosa

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Pathophysiologic hypotheses are involving the trouble of the microbiota-gut-brain axis in the field of mental diseases.

Detailed description

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Here we aim to characterize the IgA-coated fraction of bacteria from the intestinal microbiota, linked to the regulation of the mucosal immune system and the epithelium physiology. Abnormalities of this microbiota are reported in inflammatory bowel disease and are associated to immune trouble. As food intake plays a key role in shaping microbiota, we aim to correlate data from IgA microbiota to food intake specificity, and to anorexia nervosa phenotypes.

Conditions

Interventions

TypeNameDescription
OTHERStool samplePurification by affinity of the IgA coated bacteria from a fecal solution. Genomic analysis of the bacteria for diversity and richness
OTHERFood intake evaluationMeasure (by survey) of food group intake for : lipids /proteins / fibers / carbohydrates

Timeline

Start date
2023-10-13
Primary completion
2023-11-28
Completion
2024-02-02
First posted
2023-05-06
Last updated
2025-11-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05842343. Inclusion in this directory is not an endorsement.